The FDA Approves the Very first CAR-T Cell Therapy for Cancer

The FDA has approved Novartis’ CAR-T therapy Kymriah, opening the way for a fresh generation of cell therapy treatments against cancer.

Novartis’ Kymriah (tisagenlecleucel), formerly known as CTL019, has become the very first gene-modified cell therapy approved in the US. Contine reading →